Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease

Genes and Immunity

Volumn 5, Issue 5, 2004, Pages 381-388

  Koeleman, B P C ^a,b   Lie, B A ^c   Undlien, D E ^d   Dudbridge, F ^e   Thorsby, E ^c   de Vries, R R P ^a   Cucca, F ^f   Roep, B O ^a   Giphart, M J ^a   Todd, J A ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e United Kingdom Human Genome Mapping Project Resource Centre   (United Kingdom)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Genotype risk; HLA; Type 1 diabetes

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPISTASIS; ETHNOLOGY; FAMILY; GENE LOCUS; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIMERIZATION; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; RISK;

EID: 4344648997     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364106     Document Type: Article

References (45)

1. Cucca F, Todd JA. HLA susceptibility to type 1 diabetes: methods and mechanisms. In: Browning MJ, McMichael AJ (eds). HLA and MHC: Genes, Molecules and Function. BIOS Scientific Publishers Ltd: Oxford, 1996, pp 23-60.
2. Cucca F, Lampis R, Congia M et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001; 10: 2025-2037.
3. Thorsby E, Undlien D. The HLA associated predisposition to type 1 diabetes and other autoimmune diseases. J Pediatr Endocrinol Metab 1996; 9 (Suppl 1): 75-88.
4. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited [see comments]. Immunol Today 1996; 17: 323-329.
5. Cucca F, Muntoni F, Lampis R et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993; 37: 85-94.
6. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-1148.
7. Ronningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991; 37: 105-111.
8. Sheehy MJ, Scharf SJ, Rowe JR et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989; 83: 830-883.
9. Schipper RF, Koeleman BP, Bruining GJ et al. HLA class II associations with type 1 diabetes mellitus: a multivariate approach. Tissue Antigens 2001; 57: 144-150.
10. Erlich HA, Zeidler A, Chang J et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 1993; 3: 358-364.
11. Park YS, Wang CY, Ko KW et al. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum Immunol 1998; 59: 794-801.
12. Mijovic CH, Jenkins D, Jacobs KH, Penny MA, Fletcher JA, Barnett AH. HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes 1991; 40: 748-753.
13. Johansson S, Lie BA, Todd JA et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun 2003; 4: 46-53.
14. Zavattari P, Lampis R, Motzo C et al. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet 2001; 10: 881-889.
15. Undlien DE, Friede T, Rammensee HG et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
16. Thomson G, Motro U, Selvin S. Statistical aspects of measuring the strength of associations between HLA antigens and diseases. Tissue Antigens 1983; 21: 320-332.
17. Payami H, Joe S, Farid NR et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989; 45: 541-546.
18. Cordell H, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control of family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-141.
19. Koeleman BP, Dudbridge F, Cordell HJ, Todd JA. Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: the Conditional Extended Transmission/Disequilibrium Test. Ann Hum Genet 2000; 64: 207-213.
20. Cordell HJ. Effect of recombination, ascertainment, and multiple affected offspring on case/pseudo-control analysis. Genet Epidemiol 2003; 25: 244.
21. Thomson G, Robinson WP, Kuhner MK et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988; 43: 799-816.
22. Chuang LM, Wu HP, Tsai WY, Lin BJ, Tai TY. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families. Diabetes Care 1995; 18: 1483-1486.
23. Ronningen KS, Markussen G, Iwe T, Thorsby E. An increased risk of insulin-dependent diabetes mellitus (IDDM) among HLA-DR4,DQw8/DRw8,DQw4 heterozygotes. Hum Immunol 1989; 24: 165-173.
24. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997; 53: 1-11.
25. Nepom BS, Schwarz D, Palmer JP, Nepom GT. Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes 1987; 36: 114-117.
26. Reichstetter S, Kwok WW, Nepom GT. Impaired binding of a DQ2 and DQ8-binding HSV VP16 peptide to a DQA1*0501/DQB1* 0302 trans class II heterodimer. Tissue Antigens 1999; 53: 101-105.
27. Thorsby E, Caillat-Zucman S, Dorman J et al. Additional disease predisposing genes in the HLA complex. A summary of the 13.IHWS disease component studies. HLA 2004. Immunobiology of the Human MHC.
28. Kwok WW, Kovats S, Thurtle P, Nepom GT. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J Immunol 1993; 150: 2263-2272.
29. Nepom GT, Kwok WW. Molecular basis for HLA-DQ associations with IDDM. Diabetes 1998; 47: 1177-1184.
30. Undlien DE, Kockum I, Ronningen KS et al. HLA association in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes. Tissue Antigens 1999; 54: 543-551.
31. Sant AJ, Germain RN. Intracellular competition for component chains determines class II MHC cell surface phenotype. Cell 1989; 57: 797-805.
32. Vader W, Stepniak D, Kooy Y et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003; 100: 12390-12395.
33. Mignot E, Lin L, Rogers W et al. Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplex in three ethnic groups. Am J Hum Genet 2001; 68: 686-699.
34. Reichstetter S, Kwok WW, Kochik S, Koelle DM, Beaty JS, Nepom GT. MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition. Hum Immunol 1999; 60: 608-618.
35. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1992; 35: 419-424.
36. Cucca F, Muntoni F, Lampis R et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993; 37: 85-94.
37. Cucca F, Lampis R, Frau F et al. The distribution of DR4 haplotypes in Sardinia suggest a primary association of type 1 diabetes with DRB1 and DQB1 loci. Hum Immunol 1995; 43: 301-308.
38. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 2001; 16: 274-278.
39. Auger I, Roudier J. HLA-DR and the development of rheumatoid arthritis. Autoimmunity 1997; 26: 123-128.
40. Zamani M, Cassiman JJ. Reevaluation of the importance of polymorphic HLA class II alleles and amino acids in the susceptibility of individuals of different populations to type I diabetes. Am J Med Genet 1998; 76: 183-194.
41. Djoulah S, Busson M, Sasazuki T et al. A new predictive model for insulin-dependent diabetes mellitus susceptibility based on combinations of molecular HLA-DRB1 and HLA-DQB1 pockets. Tissue Antigens 1999; 54: 341-348.
42. Self SG, Longton G, Kopecky KJ, Liang KY. On estimating HLA/disease association with application to a study of aplastic anemia. Biometrics 1991; 47: 53-56.
43. Schaid DJ, Sommer SS. Genotype relative risks: methods for design and analysis of candidate-gene association studies. Am J Hum Genet 1993; 53: 1114-1126.
44. Schaid DJ. Likelihoods and TDT for the case-parents design. Genet Epidemiol 1999; 16: 250-260.
45. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323-336.